Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG

Approved

STANDARD

ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG

Laboratorios Liconsa S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 18, 2024
Approval ID: c19996641f2cafe8
Company: Laboratorios Liconsa S.A.
Type: Standard

Approval Details

Approval Id: c19996641f2cafe8
Drug Cima Aemps Name: ARIPIPRAZOL LABORATORIOS LICONSA 5 MG COMPRIMIDOS EFG
Register Number: 88891
Holder Company Name: Laboratorios Liconsa S.A.
Marketing Company Name: Laboratorios Liconsa S.A.
Holder Company Detail Path: /organization/laboratorios-liconsa-sa
Marketing Company Detail Path: /organization/laboratorios-liconsa-sa
Authorization Date: 2024-01-18
Dosage Form: COMPRIMIDO
Dose: 5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Laboratorios Liconsa S.A.
Company Detail Path: /organization/laboratorios-liconsa-sa

Company Information

Pharmaceutical Company Name: Laboratorios Liconsa SA
Country Name: Spain

Active Ingredients

ARIPIPRAZOL

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 18, 2024

Approval ID

c19996641f2cafe8

Type

Standard

Back to CIMA-AEMPS Approvals